Credence MedSystems Honored Again, Awarded the Innovation First Prize at Pharmapack for its Novel Drug Delivery System

For the second time in 2 weeks, the Credence Companion Safety Syringe System was awarded the Top Prize in Innovation at a major pharmaceutical conference.


MENLO PARK, Calif., Feb. 24, 2015 (GLOBE NEWSWIRE) -- via PRWEB - The Credence Companion Safety Syringe System was honored with First Prize in the Innovation Awards at the Pharmapack Europe conference in Paris, the Company announced today. This comes less than two weeks after the Companion won the award for the Best and Most Innovative Advancement in Drug Delivery at the Drug Delivery Partnerships (DDP) meeting on January 30.

Pharmapack Europe traditionally attracts over 350 exhibitors and over 3,100 visitors all focused on packaging and drug delivery technology for the pharmaceutical industry. The Companion was judged by a panel of industry experts to be the most innovative technology in the exhibitor category.

"This is a great honor for the entire company and specifically the inventors on the development team," stated Jeff Tillack, Credence's COO. "The fact that it has happened just days after the DDP award adds to the excitement. The awards have come alongside the launch of our new Staked Needle version of the Companion. We are really pleased with the feedback."

A staked, or pre-attached, needle minimizes the steps a user must take before injecting and eliminates the chances of error when connecting a needle. The Credence system allows the needle to come pre-attached, but does not include the glue that conventional syringes use to hold the needle in place. This eliminates the risk of unwanted and unsafe interaction between the glue and the liquid drug. At the end of the injection, the needle retracts back into the barrel of the syringe rendering the syringe auto-disabled and safe from needlesticks.

Credence's core philosophy of Innovation Without Change led directly to the Companion's development. Whether with the pre-attached needle version or the user-attached needle ('luer') version, the Companion uses existing pre-filled syringe and primary drug package components in order to avoid much of the development and regulatory challenges commonly associated with drug delivery products. The result is a best-in-class drug delivery device with a simplified path to market for pharmaceutical and biotech companies.

About Credence MedSystems, Inc.

Credence MedSystems is a medical technology and specialty pharmaceutical company focused on delivering medications safely for the benefit of our patients, caregivers and partners. The Credence Companion Safety Syringe System combines passive retractable needle safety with a modular approach that leaves the primary drug container unchanged, a major advantage for our pharmaceutical and biotechnology partners. Credence is also developing the expertise to provide our customers single-dose injectable medications in prefilled syringes.

info(at)CredenceMed(dot)com

http://www.CredenceMed.com

+1-844-263-3797 (844-CMEDSYS)

This article was originally distributed on PRWeb. For the original version including any supplementary images or video, visit http://www.prweb.com/releases/2015/02/prweb12536619.htm


            

Contact Data